Pure Global AI
ANVISA registration 81062710055Valid until Jan 02, 2034

CHROMOSOMAL TRANSLOCATION BCR-ABL (PHILADELPHIA CHROMOSOME)

ANVISA Registration Number: 81062710055Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltdaCEPHEIDRisk Class III
Device names
Technical name
CHROMOSOMAL TRANSLOCATION BCR-ABL (PHILADELPHIA CHROMOSOME)
PT: TRANSLOCAÇÃO CROMOSSÔMICA BCR-ABL (CROMOSSOMO PHILADELPHIA)
Commercial name
Xpert BCR-ABL Ultra p190
Risk class
Class III
Registration details
Registration Number
81062710055
Process Number
25351579076202317
CNPJ
18628083000123
Company information
Manufacturer
CEPHEID
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Jan 02, 2024
Validity
02/01/2034
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for CHROMOSOMAL TRANSLOCATION BCR-ABL (PHILADELPHIA CHROMOSOME) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81062710055 and manufactured by CEPHEID. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Jan 02, 2034.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.